CAS: 40691-33-6; Dichlorobis(Tri-O-Tolylphosphine)Palladium(Ii)

上下游产品

tris-(o-tolyl)phosphine 4-(3-(3-[bis[(1,1-dimethylethoxy)carbonyl]amino]-4-methylphenyl)-1,2,4-oxadiazol-5-yl)-1,1,1-trifluoro-2-methylbutan-2-ol methyl iodide dichloro(1,5-cyclo°Ctadiene)palladium(II)chloro-(pyrine-6-thiolato)(tris-o-tolylphosphine)palladium(II) (0)bis(tri-ortho-tolylphosphine)palladium(0) chloro-(pyrimidine-2-thiolato)(tris-o-tolylphosphine)palladium(II) [Pd(1,2,3,4-tetrahydroisoquinolinedithi°Carbamate)(tri-o-tolylphosphine)Cl]

二(氰基苯)二氯化钯,三(邻甲基苯基)磷 以 甲苯 作为反应溶剂,以66%的收率获得产物二氯双(三邻甲苯膦)合钯(II)
参考文献:邻异丙基苯基基团的特殊作用.螺旋手性par3配体的铂(II)和钯(II)配合物中的非对映异构.
标题:邻异丙基苯基基团的特殊作用.螺旋手性par3配体的铂(II)和钯(II)配合物中的非对映异构.
摘要:四种膦的配位化学,P {c6H3(o-Ch3)(pz)} 3其中z = H(1A)或ome(1B)和p {c6H3(o-Chme2)(pz)} 3 Z = H (1C)或ome(1D)中含有铂(II)和钯(II).制备了单核复合物反式[pdcl2L2](l = 1A,B)和反式[ptcl2L2](l = 1A-C),反式[pdcl2(1B)2]和反式[ptcl2(1C)2],因为它们的二氯甲烷溶剂化物已经确定.结构表明,在这些络合物中,配体采用g + G + A构象.剑桥结构数据库的检查确认这是三邻甲苯基膦所采用的仅有的两种构象异构体之一,并且是4和6配合物中唯一可行的构象异构体.即使过量的大体积1C,也会形成双核复合物反式-[pd2Cl4L2](l = 1C,D),D用于合成中,并报道了反式-[pd2Cl4(1C)2]的氯仿溶剂化物的晶体结构.[ptcl2(ncbu(t))2]与1B-
DOI:10.1039/b416525J

专利信息

专利号:US-11059835-B2
优先权日:2014-08-15
标 题 :Synthesis of cephalosporin compounds
发明人：WALLER DAVID; GAZDA GREGORY; MINDEN ZACHARY; BARTON LISA; LEIGH CLIFTON
权利人:MERCK SHARP & DOHME
摘要:Provided herein is a method for the synthesis of cephalosporin antibiotic compounds comprising a palladium-catalyzed coupling reaction.

专利号:US-10457640-B2
优先权日:2016-10-19
标 题:Synthesis of inhibitors of EZH2
发明人：VASWANI RISHI G; HEWITT MICHAEL CHARLES
权利人:CONSTELLATION PHARMACEUTICALS INC
摘要:Provided herein are synthetic methods for the preparation of EZH2 inhibitors.

专利号:US-2019233375-A1
优先权日:2016-10-19
标题:Synthesis of inhibitors of ezh2

专利号:EP-3180347-B1
优先权日:2014-08-15
标 题:Synthesis of cephalosporin compounds

专利号:EP-3529242-A1
优先权日:2016-10-19
标 题 :Synthesis of inhibitors of ezh2

专利号:WO-2018075598-A1
优先权日:2016-10-19
标题 :Synthesis of inhibitors of ezh2